Literature DB >> 28847155

Clinical description of attack-related cognitive symptoms in migraine: A systematic review.

Raquel Gil-Gouveia1,2, Isabel Pavão Martins2.   

Abstract

Introduction Cognitive symptoms have been described during migraine attacks since the Roman era; while being neglected throughout the centuries, they are relevant contributors to migraine-related disability. Objective To determine whether cognitive symptoms are included in clinical series describing migraine attack phenomenology, and which symptoms occur in each attack phase. Method Systematic review of existing data on clinical descriptions of migraine attacks, focusing on cognitive symptomatology. Data were organized and analyzed qualitatively, due to methodological differences between studies. Results Twenty-four articles were reviewed, with a total sample of 7007 patients, including 82.9% females with an average age of 39.2 years. Twenty one (75%) studies analyzed one phase of the attack (eight prodromes, five auras, one between aura and pain, three headaches and three postdromes), the remaining studied more than one phase. Cognitive complaints were the most frequent symptom of the prodromic (30%) and headache (38%) phases, while fatigue (70%) dominated the resolution phase. Not enough data is available to estimate the frequency of cognitive symptoms during the aura. Discussion Cognitive symptoms are described in all phases of the migraine attack phenomenology in published clinical series of migraine. Their characteristics appear to be different in each attack phase, although methodological limitations prevent generalization of this finding.

Entities:  

Keywords:  Migraine; cognition; headache; review

Mesh:

Year:  2017        PMID: 28847155     DOI: 10.1177/0333102417728250

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

Review 1.  Cognition and Cognitive Impairment in Migraine.

Authors:  Raquel Gil-Gouveia; Isabel Pavão Martins
Journal:  Curr Pain Headache Rep       Date:  2019-09-11

2.  Headache Gauge: a real-life calendar-based tool for headache monitoring.

Authors:  Raquel Gil-Gouveia; Inês Brás Marques; Elsa Paixão Parreira; Isabel Pavão Martins; António Gouveia Oliveira
Journal:  Neurol Sci       Date:  2021-02-04       Impact factor: 3.307

3.  Migraine among students of a medical college in western China: a cross-sectional study.

Authors:  Haodi Yang; Shengxiong Pu; Yang Lu; Wenxiu Luo; Jiayu Zhao; Enzhuo Liu; Jiaming Yang; Xinya Luo; Xinyi Tang; Cheng Zeng; Jie Chen; Jiaming Luo
Journal:  Eur J Med Res       Date:  2022-05-23       Impact factor: 4.981

Review 4.  Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review.

Authors:  Samuela Tarantino; Martina Proietti Checchi; Laura Papetti; Fabiana Ursitti; Giorgia Sforza; Michela Ada Noris Ferilli; Romina Moavero; Gabriele Monte; Teresa Grimaldi Capitello; Federico Vigevano; Massimiliano Valeriani
Journal:  Front Neurol       Date:  2022-07-13       Impact factor: 4.086

Review 5.  Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Hum Neurosci       Date:  2021-06-03       Impact factor: 3.169

Review 6.  Imaging the Premonitory Phase of Migraine.

Authors:  Nazia Karsan; Peter J Goadsby
Journal:  Front Neurol       Date:  2020-03-25       Impact factor: 4.003

Review 7.  The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings.

Authors:  Stewart J Tepper; Stephen D Silberstein; Noah L Rosen; Richard B Lipton; Ellen B Dennehy; Sherie A Dowsett; Erin Doty
Journal:  Headache       Date:  2019-12-02       Impact factor: 5.887

8.  Premonitory symptoms in glyceryl trinitrate triggered migraine attacks: a case-control study.

Authors:  Gerrit L J Onderwater; Jitze Dool; Michel D Ferrari; Gisela M Terwindt
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.